Drugs / Standard dose Influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02461758 | Oct 2016 → Jun 2018 | inflammatory bowel disease | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard dose Influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02461758 ↗ |
| Known as | SDIV | “Standard dose Influenza vaccine (SDIV)” NCT02461758 ↗ |
| Modality | Vaccine | “standard dose influenza vaccine” NCT02461758 ↗ |